NCT01013350View on ClinicalTrials.gov

Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants Who Have Participated in Cladribine Clinical Trials

CompletedOBSERVATIONAL
Enrollment

1,161

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

October 25, 2018

Study Completion Date

October 25, 2018

Conditions
Multiple Sclerosis
Trial Locations (1)

02139

Outcome Sciences, Inc, Cambridge

Sponsors

Lead Sponsor

EMD Serono
All Listed Sponsors
lead

EMD Serono

INDUSTRY

NCT01013350 - Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants Who Have Participated in Cladribine Clinical Trials | Biotech Hunter | Biotech Hunter